Umifenovir Epigenetically Targets the <i>IL-10</i> Pathway in Therapy against Coxsackievirus B4 Infection-Reference-Cited by-同舟云学术

Umifenovir Epigenetically Targets the IL-10 Pathway in Therapy against Coxsackievirus B4 Infection

Published:2023-02-14 Issue:1 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Zhang Shilin¹^ORCID,Xue Xiao²,Qiao Sennan³,Jia Lin¹,Wen Xue¹,Wang Yichen¹,Wang Cong¹,Li Hongrui³,Cui Jiuwei¹

Affiliation:

1. Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Cancer Center, First Hospital of Jilin University, Changchun, Jilin, People’s Republic of China

2. Department of Clinical Laboratory, First Hospital of Jilin University, Changchun, Jilin, People’s Republic of China

3. Institute of Frontier Medical Science of Jilin University, Changchun, Jilin, People’s Republic of China

Abstract

Viral infections are major threats to human health because of their strong association with a variety of inflammation-related diseases, especially cancer. Many antiviral drugs are performing poorly in treating viral infections.

Funder

Jilin Provincial Science and Technology Department

National Natural Science Foundation of China

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.04248-22

Reference59 articles.

1. Redefining Chronic Viral Infection

2. Human Oncoviruses and Thoracic Tumors: Understanding the Imaging Findings

3. Searching for human oncoviruses: Histories, challenges, and opportunities

4. Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection

5. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro